Error control coding: from theory to practice

por Sweeney, Peter
Publicado 2002

A randomized control trial of a psychosocial intervention for caregivers of allogeneic hematopoietic stem cell transplant patients: Effects on distress

por Laudenslager, Mark L., Simoneau, Teri L., Kilbourn, Kristin, Natvig, Crystal, Philips, Sam, Spradley, Janet, Benitez, Patrick, McSweeney, Peter, Mikulich-Gilbertson, Susan K.
Publicado 2015

Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)

por Battiwalla, Minoo, Bachier, Carlos, Bhushan, Vikas, Eckrich, Michael J., Eghtedar, Alireza, Frangoul, Haydar, Kambhampati, Suman, Malik, Shahbaz, McSweeney, Peter A., Pantin, Jeremy, Ramakrishnan, Aravind, Safah, Hana, Shaughnessy, Paul J, Blunk, Betsy, Cox, Tonya, Billups, Rocky, Lemaistre, Charles F.
Publicado 2020

Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis

por Adamska, Julia Z, Zia, Amin, Bloom, Michelle S, Crofford, Leslie J, Furst, Daniel E, Goldmuntz, Ellen, Keyes-Elstein, Lynette, Mayes, Maureen D, McSweeney, Peter, Nash, Richard A, Pinckney, Ashley, Welch, Beverly, Love, Zelda Z, Sullivan, Keith M, Robinson, William
Publicado 2023

Remission of severe myasthenia gravis after autologous stem cell transplantation

por Schlatter, Monica I., Yandamuri, Soumya S., O'Connor, Kevin C., Nowak, Richard J., Pham, Minh C., Obaid, Abeer H., Redman, Callee, Provost, Marie, McSweeney, Peter A., Pearlman, Michael L., Tees, Michael T., Bowen, James D., Nash, Richard A., Georges, George E.
Publicado 2023

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results

por Bowen, James D., Kraft, George H., Wundes, Annette, Guan, QingYan, Maravilla, Kenneth R., Gooley, Theodore A., McSweeney, Peter A., Pavletic, Steven Z., Openshaw, Harry, Storb, Rainer, Wener, Mark, McLaughlin, Bernadette A., Henstorf, Gretchen R., Nash, Richard A.
Publicado 2011

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

por Maffini, Enrico, Storer, Barry E., Sandmaier, Brenda M., Bruno, Benedetto, Sahebi, Firoozeh, Shizuru, Judith A., Chauncey, Thomas R., Hari, Parameswaran, Lange, Thoralf, Pulsipher, Michael A., McSweeney, Peter A., Holmberg, Leona, Becker, Pamela S., Green, Damian J., Mielcarek, Marco, Maloney, David G., Storb, Rainer
Publicado 2019

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation

por Ayoglu, Burcu, Donato, Michele, Furst, Daniel E, Crofford, Leslie J, Goldmuntz, Ellen, Keyes-Elstein, Lynette, James, Judith, Macwana, Susan, Mayes, Maureen D, McSweeney, Peter, Nash, Richard A, Sullivan, Keith M, Welch, Beverly, Pinckney, Ashley, Mao, Rong, Chung, Lorinda, Khatri, Purvesh, Utz, Paul J
Publicado 2023

Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience

por Shadman, Mazyar, Maloney, David G., Storer, Barry, Sandmaier, Brenda M., Chauncey, Thomas R., Andersen, Niels Smedegaard, Niederwieser, Dietger, Shizuru, Judith, Bruno, Benedetto, Pulsipher, Michael A., Maziarz, Richard T., Agura, Edward D., Hari, Parameswaran, Langston, Amelia A., Maris, Michael B., McSweeney, Peter A, Storb, Rainer, Sorror, Mohamed L.
Publicado 2019

Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study

por Wang, Michael, Munoz, Javier, Goy, Andre, Locke, Frederick L., Jacobson, Caron A., Hill, Brian T., Timmerman, John M., Holmes, Houston, Jaglowski, Samantha, Flinn, Ian W., McSweeney, Peter A., Miklos, David B., Pagel, John M., Kersten, Marie José, Bouabdallah, Krimo, Khanal, Rashmi, Topp, Max S., Houot, Roch, Beitinjaneh, Amer, Peng, Weimin, Fang, Xiang, Shen, Rhine R., Siddiqi, Rubina, Kloos, Ioana, Reagan, Patrick M.
Publicado 2023

Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma

por Oluwole, Olalekan O., Bouabdallah, Krimo, Muñoz, Javier, De Guibert, Sophie, Vose, Julie M., Bartlett, Nancy L., Lin, Yi, Deol, Abhinav, McSweeney, Peter A., Goy, Andre H., Kersten, Marie José, Jacobson, Caron A., Farooq, Umar, Minnema, Monique C., Thieblemont, Catherine, Timmerman, John M., Stiff, Patrick, Avivi, Irit, Tzachanis, Dimitrios, Kim, Jenny J., Bashir, Zahid, McLeroy, Jeff, Zheng, Yan, Rossi, John M., Johnson, Lisa, Goyal, Lovely, van Meerten, Tom
Publicado 2021

Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma

por Neelapu, Sattva S., Jacobson, Caron A., Ghobadi, Armin, Miklos, David B., Lekakis, Lazaros J., Oluwole, Olalekan O., Lin, Yi, Braunschweig, Ira, Hill, Brian T., Timmerman, John M., Deol, Abhinav, Reagan, Patrick M., Stiff, Patrick, Flinn, Ian W., Farooq, Umar, Goy, Andre H., McSweeney, Peter A., Munoz, Javier, Siddiqi, Tanya, Chavez, Julio C., Herrera, Alex F., Bartlett, Nancy L., Bot, Adrian A., Shen, Rhine R., Dong, Jinghui, Singh, Kanwarjit, Miao, Harry, Kim, Jenny J., Zheng, Yan, Locke, Frederick L.
Publicado 2023